AstraZeneca
1,697.5 SEK +1.8%17 investors are following this company
AstraZeneca is a global biopharmaceutical company that focuses on the research, development, and marketing of prescription drugs, primarily for the treatment of diseases in the areas of therapy that affect the respiratory tract, cardiovascular / metabolism, and cancer. In addition to its main operations, the company is also active in autoimmunity, neuroscience, and infection. AstraZeneca is active in all global regions and is headquartered in Cambridge.
Revenue
-
EBIT %
-
P/E
43.82
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
AZN
Daily low / high price
1,683.5 / 1,713
SEK
Market cap
2.63T SEK
Turnover
317.78M SEK
Volume
187K
Financial calendar
Half year dividend
08.08.2024
Interim report
12.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
BlackRock, Inc. | 7.0 % | 7.0 % |
The Capital Group Companies | 5.0 % | 5.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
AstraZeneca: Filing of Form 20-F with SEC
AstraZeneca: 9M and Q3 2023 results
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools